Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24113030 | 1.00 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL28850128 | 1.00 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL31556728 | 0.90 | MEN1 (0.52) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL28994850 | 0.90 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL24766583 | 0.90 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL30540076 | 0.90 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL24766074 | 0.90 | HPGD (0.49) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL1262547 | 0.90 | HPGD (0.55) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL28683024 | 0.87 | HPGD (0.47) | HPGDRECQLEPHX1MAPTUSP2 | |
| SCHEMBL2625518 | 0.86 | HPGD (0.51) | HPGDRECQLEPHX1MAPTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12336991-B2 | Factor XIIA inhibitors | UNIVERSITY OF LEEDS (GB) | 2025-06-24 | — | — | US | disclosed |
| US-20220305011-A1 | FACTOR XIIA INHIBITORS | UNIVERSITY OF LEEDS (GB) | 2022-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220305011-A1 | FACTOR XIIA INHIBITORS | F11, F13B, F12 | HPGD 675/4885RECQL 1842/4885EPHX1 382/4885 |
| US-12336991-B2 | Factor XIIA inhibitors | F11, F13B, F12 | HPGD 675/4885RECQL 1842/4885EPHX1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.